ConductScience.org, home

Paper5770101

Reaction of a cobra venom factor with guinea pig complement and generation of an activity chemotactic for polymorphonuclear leukocytes.

Shin HS and 2 others. Proc Soc Exp Biol Med, 1969. Cited by 85 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Reaction of a cobra venom factor with guinea pig complement and generation of an activity chemotactic for polymorphonuclear leukocytes. Papers, record 5770101. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/5770101

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Reaction of a cobra venom factor with guinea pig complement and generation of an activity chemotactic for polymorphonuclear leukocytes.
PubMed
Journal
Proc Soc Exp Biol Med
PubMed
Year
1969
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
85
iCite
Revised in PubMed
2020-09-30
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Shin HSH S
2Gewurz HH
3Snyderman RR

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Complement System ProteinsMajor topic
LeukocytesMajor topic
VenomsMajor topic
Animals
Antigen-Antibody Reactions
Cell Biology
Chemotaxis
Electrophoresis, Disc
Guinea Pigs
In Vitro Techniques
Snakes

Source PubMed

Download CSV of topics

Cited by26

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 85 citations.

PMIDTitleJournalYearIn PapersSource
16557862Histamine-releasing factor generated by the interaction of endotoxin with hamster serum.Infect Immun1970https://conductscience.org/library/papers/16557862PubMed
16557796Complement in endotoxin shock: effect of complement depletion on the early hypotensive phase.Infect Immun1970https://conductscience.org/library/papers/16557796PubMed
16557770Polymorphonuclear leukocyte chemotactic activity in rabbit serum and Guinea pig serum treated with immune complexes: evidence for c5a as the major chemotactic factor.Infect Immun1970https://conductscience.org/library/papers/16557770PubMed
8782350Involvement of the complement system in the protection of mice from challenge with respiratory syncytial virus Long strain following passive immunization with monoclonal antibody 18A2B2.Vaccine1996https://conductscience.org/library/papers/8782350PubMed
7921595Pro-inflammatory activities in elapid snake venoms.Br J Pharmacol1994https://conductscience.org/library/papers/7921595PubMed
5470510Complement and complement-like activity in lower vertebrates and invertebrates.J Exp Med1970https://conductscience.org/library/papers/5470510PubMed
5042921The serologic behaviour of neuraminidase-treated lymphoid cells. Alloantigenicity and complement sensitivity.Clin Exp Immunol1972https://conductscience.org/library/papers/5042921PubMed
4992784Studies on eosinophil leucocyte migration. II. Factors specifically chemotactic for eosinophils and neutrophils generated from guinea-pig serum by antigen-antibody complexes.Clin Exp Immunol1970https://conductscience.org/library/papers/4992784PubMed
4825618The effect of complement depletion on wound healing.Am J Pathol1974https://conductscience.org/library/papers/4825618PubMed
4683877Interactions of the classical and alternate complement pathway with endotoxin lipopolysaccharide. Effect on platelets and blood coagulation.J Clin Invest1973https://conductscience.org/library/papers/4683877PubMed
4630602Escherichia coli bacteremia in the squirrel monkey. I. Effect of cobra venom factor treatment.J Clin Invest1973https://conductscience.org/library/papers/4630602PubMed
4398349Interaction of toxic venoms with the complement system.Immunology1971https://conductscience.org/library/papers/4398349PubMed
4390900Heat labile opsonins to pneumococcus. II. Involvement of C3 and C5.J Exp Med1969https://conductscience.org/library/papers/4390900PubMed
4390899Heat labile opsonins to pneumococcus. I. Participation of complement.J Exp Med1969https://conductscience.org/library/papers/4390899PubMed
4335984Comparative effect of viral and bacterial neuraminidase on the complement sensitivity of lymphoid cells.Clin Exp Immunol1972https://conductscience.org/library/papers/4335984PubMed
4263696Specific inactivation of the fourth complement component. I. In vivo studies.Infect Immun1971https://conductscience.org/library/papers/4263696PubMed
4193936Interactions of the complement system with endotoxic lipopolysaccharides in immunoglobulin-deficient sera.J Exp Med1970https://conductscience.org/library/papers/4193936PubMed
4106805An eosinophil leukocyte chemotactic factor of anaphylaxis.J Exp Med1971https://conductscience.org/library/papers/4106805PubMed
1204249Cytolysis of neuraminidase-treated autochthonous lymphoid cells by autologous serum.Clin Exp Immunol1975https://conductscience.org/library/papers/1204249PubMed
1171082Studies on the inhibition of C56-initiated lysis (reactive lysis). V. The roleof C567-INH in the regulation of complement-dependent haemolysis initiated by cobravenom factor.Immunology1975https://conductscience.org/library/papers/1171082PubMed

See all 26 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/5770101

GET https://conductscience.org/api/papers/v1/5770101/cited_by?page=2